Five FDA ophthalmology updates you might have missed

The FDA has issued multiple approvals and denials of drugs, formulations and devices over the past month.
Here are five recent ophthalmology-related FDA actions you might have missed:
Alembic s generic dorzolamide hydrochloride solution approved
Indicated for the treatment of elevated IOP in ocular hypertension or open-angle glaucoma patients, it is therapeutically equivalent to Trusopt ophthalmic solution 2% (Merck). Read more.
FDA approves Eylea prefilled syringe
The 2-mg, single-dose, sterilized prefilled Eylea (aflibercept) syringe, which requires fewer preparation steps compared

Full Story →